Assessment of the Prevalence and Incidence of COVID-19 in Saudi Arabia

References

• World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV; 2020. Available from:http://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed January 21, 2023.
   Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Paules CI, Marston HD, Fauci AS. Coronavirus infections—more than just the common cold. JAMA. 2020;323(8):707. doi:10.1001/jama.2020.0757
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Eng J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Chambers JP, Yu J, Valdes JJ, Arulanandam BP. SARS-CoV-2, early entry events. J Pathog. 2020;2020:1–11. doi:10.1155/2020/9238696
   Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Ni W, Yang X, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422. doi:10.1186/s13054-020-03120-0
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001
   PubMed Web of Science ®Google Scholar
• Duong D. What’s important to know about the new COVID-19 variants? Can Med Assoc J. 2021;193(4):E141–E142. doi:10.1503/cmaj.1095915
   Web of Science ®Google Scholar
• Eaaswarkhanth M, Al Madhoun A, Al-Mulla F. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality? Int J Infect Dis. 2020;96:459–460. doi:10.1016/j.ijid.2020.05.071
   PubMed Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking Changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827.e19. doi:10.1016/j.cell.2020.06.043
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease 2019 (COVID-19) situation report – 82. data as received by WHO from national authorities by 10:00 CET; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200411-sitrep-82-covid-19.pdf?sfvrsn=74a5d15_2. Accessed January 21, 2023.
   Google Scholar
• Bazykin GA, So DD. Emergence of Y453F and Δ69-70HV mutations in a lymphoma patient with long-term COVID-19. Available from: https://virological.org/t/emergence-of-y453f-and-69-70hv-mutations-in-a-lymphoma-patient-with-long-term-covid-19/580.
   Google Scholar
• European Centre for Disease Prevention and Control. Rapid increase of a SARS- CoV-2 variant with multiple spike protein mutations observed in the United Kingdom; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein-mutations-United-Kingdom.pdf. Accessed January 21, 2023.
   Google Scholar
• NERVTAG meeting. SARS-CoV-2 variant under investigation VUI-202012/01. Avaliable from: https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756963730457. Accessed January 21, 2023.
   Google Scholar
• Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538). doi:10.1126/science.abg3055
   Web of Science ®Google Scholar
• World Health Organization. SARS-CoV-2 Variants. World Health Organization. Available from:https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/. Accessed January 21, 2023.
   Google Scholar
• Volz E, Mishra S, Chand M, et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269. doi:10.1038/s41586-021-03470-x
   PubMed Web of Science ®Google Scholar
• Galloway SE, Paul P, MacCannell DR, et al. Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(3):95–99. doi:10.15585/mmwr.mm7003e2
   PubMed Web of Science ®Google Scholar
• Yi C, Sun X, Ye J, et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020;17(6):621–630. doi:10.1038/s41423-020-0458-z
   PubMed Web of Science ®Google Scholar
• Gu H, Chen Q, Yang G, et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020;369(6511):1603–1607. doi:10.1126/science.abc4730
   PubMed Web of Science ®Google Scholar
• Starr TN, Greaney AJ, Hilton SK, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020;182(5):1295–1310.e20. doi:10.1016/j.cell.2020.08.012
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78(4):779–784.e5. doi:10.1016/j.molcel.2020.04.022
   PubMed Web of Science ®Google Scholar
• Kemp SA, Collier DA, Datir RP, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592(7853):277–282. doi:10.1038/s41586-021-03291-y
   PubMed Web of Science ®Google Scholar
• Meng B, Kemp SA, Papa G, et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 2021;35(13):109292. doi:10.1016/j.celrep.2021.109292
   PubMed Web of Science ®Google Scholar
• Public Health England. Investigation of novel SARS-CoV-2 variant: variant of concern. Technical briefing 5; 2020. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/957504/Variant_of_Concern_VOC_202012_01_Technical_Briefing_5_England.pdf. Accessed January 21, 2023.
   Google Scholar
• Mahase E. Covid-19: what new variants are emerging and how are they being investigated? BMJ. 2021;2021:n158. doi:10.1136/bmj.n158
   Google Scholar
• Greaney AJ, Loes AN, Crawford KHD, et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021;29(3):463–476.e6. doi:10.1016/j.chom.2021.02.003
   PubMed Web of Science ®Google Scholar
• Nuno R. Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. Available from: https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586. Accessed January 21, 2023.
   Google Scholar
• World Health Organization. Tracking SARS-CoV-2 variants. World Health Organization. Available from:https://www.who.int/activities/tracking-SARS-CoV-2-variants. Accessed January 21, 2023.
   Google Scholar
• Kingsbury JLR. Potential for foodborne transmission of Covid-19:: literature review update. Available from: https://www.unitedfresh.co.nz/assets/COVID-19/United-Fresh---Potential-for-Foodborne-Transmission-of-Covid-19---Literature-Review-Update-19-May-20.pdf. Accessed January 21, 2023.
   Google Scholar
• Team E. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. China CDC Wkly. 2020;41(2):145–151. doi:10.3760/cma.j.issn0254-6450202002003
   Google Scholar
• PNG National Department of Health (NDoH). Coronavirus disease 2019 (COVID-19). Available from: http://mail.health.gov.pg/covid19/PNGSR23PCOVID-19(2020-05-31).pdf. Accessed January 21, 2023.
   Google Scholar
• CDC COVID-19 Response Team, Bialek S. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States; 2020. Available from: https://stacks.cdc.gov/view/cdc/99478. Accessed January 21, 2023.
   Google Scholar
• Khalil A, Kalafat E, Benlioglu C, et al. SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. 2020;25:100446. doi:10.1016/j.eclinm.2020.100446
   PubMedGoogle Scholar
• Astuti I, Srafil Y. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr. 2020;14(4):407–412. doi:10.1016/j.dsx.2020.04.020
   PubMed Web of Science ®Google Scholar
• Simmons G, Zmora P, Gierer S, Heurich A, Pöhlmann S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res. 2013;100(3):605–614. doi:10.1016/j.antiviral.2013.09.028
   PubMed Web of Science ®Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582. doi:10.7326/M20-0504
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization. Technical specifications of medical devices for the case management of COVID-19 in healthcare settings. Interim recommendations; 2020. Available from: https://iris.paho.org/handle/10665.2/51979. Accessed January 21, 2023.
   Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020:m1985. doi:10.1136/bmj.m1985
   PubMedGoogle Scholar
• Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine. 2020;29–30:100639. doi:10.1016/j.eclinm.2020.100639
   Google Scholar
• Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA. 2020;324(8):782. doi:10.1001/jama.2020.12839
   PubMed Web of Science ®Google Scholar
• Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Eng J Med. 2014;370(26):2499–2505. doi:10.1056/NEJMoa1401505
   PubMed Web of Science ®Google Scholar
• Wang LF, Shi Z, Zhang S, Field H, Daszak P, Eaton B. Review of bats and SARS. Emerg Infect Dis. 2006;12(12):1834–1840. doi:10.3201/eid1212.060401
   PubMed Web of Science ®Google Scholar
• Lam TTY, Jia N, Zhang YW, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583(7815):282–285. doi:10.1038/s41586-020-2169-0
   PubMed Web of Science ®Google Scholar
• Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931–934. doi:10.1016/S0140-6736(20)30567-5
   PubMed Web of Science ®Google Scholar
• Dhand R, Li J. Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med. 2020;202(5):651–659. doi:10.1164/rccm.202004-1263PP
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences E and M. Airborne Transmission of SARS-Cov-2. Shelton-Davenport M, Pavlin J, Saunders J, Staudt A, eds. National Academies Press; 2020.
   Google Scholar
• Guo ZD, Wang ZY, Zhang SF, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7):1583–1591. doi:10.3201/eid2607.200885
   PubMed Web of Science ®Google Scholar
• Arslan M, Xu B, Gamal El-Din M. Transmission of SARS-CoV-2 via fecal-oral and aerosols–borne routes: environmental dynamics and implications for wastewater management in underprivileged societies. Sci Total Environ. 2020;743:140709. doi:10.1016/j.scitotenv.2020.140709
   PubMed Web of Science ®Google Scholar
• Bwire GM, Njiro BJ, Mwakawanga DL, Sabas D, Sunguya BF. Possible vertical transmission and antibodies against SARS‐CoV‐2 among infants born to mothers with COVID‐19: a living systematic review. J Med Virol. 2021;93(3):1361–1369. doi:10.1002/jmv.26622
   PubMed Web of Science ®Google Scholar
• Chriscaden K. Impact of COVID-19 on people’s livelihoods, their health and our food systems. World Health Organization; 2020. Available from: https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people’s-livelihoods-their-health-and-our-food-systems#:~:Text=The%20economic%20and%20social%20disruption,the%20end%20of%20the%20year. Accessed January 21, 2023.
   Google Scholar
• Alahmari AA, Khan AA, Elganainy A, et al. Epidemiological and clinical features of COVID-19 patients in Saudi Arabia. J Infect Public Health. 2021;14(4):437–443. doi:10.1016/j.jiph.2021.01.003
   PubMed Web of Science ®Google Scholar
• Al-Rabiaah A, Temsah MH, Al-Eyadhy AA, et al. Middle east respiratory syndrome-corona virus (MERS-CoV) associated stress among medical students at a university teaching hospital in Saudi Arabia. J Infect Public Health. 2020;13(5):687–691. doi:10.1016/j.jiph.2020.01.005
   PubMed Web of Science ®Google Scholar
• Alharbi NK, Alghnam S, Algaissi A, et al. Nationwide seroprevalence of SARS-CoV-2 in Saudi Arabia. J Infect Public Health. 2021;14(7):832–838. doi:10.1016/j.jiph.2021.04.006
   PubMed Web of Science ®Google Scholar
• Alyami MH, Naser AY, Orabi MAA, Alwafi H, Alyami HS. Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: an ecological study. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00506
   PubMed Web of Science ®Google Scholar
• Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health. 2020;13(7):920–925. doi:10.1016/j.jiph.2020.05.026
   PubMed Web of Science ®Google Scholar
• Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience. J Infect Public Health. 2020;13(6):834–838. doi:10.1016/j.jiph.2020.04.016
   PubMed Web of Science ®Google Scholar
• Alandijany TA, Faizo AA, Azhar EI. Coronavirus disease of 2019 (COVID-19) in the Gulf Cooperation Council (GCC) countries: current status and management practices. J Infect Public Health. 2020;13(6):839–842. doi:10.1016/j.jiph.2020.05.020
   PubMed Web of Science ®Google Scholar
• Javed N, Zuber M, Amin S, Bugis B, Al-Mohaithef M. COVID-19 cases and deaths after implementation of prevention strategies, Saudi Arabia. East Mediterr Health J. 2022;28(2):95–107. doi:10.26719/emhj.21.067
   PubMed Web of Science ®Google Scholar
• Khan A, Alahmari A, Almuzaini Y, et al. The role of digital technology in responding to COVID-19 pandemic: Saudi Arabia’s experience. Risk Manag Healthc Policy. 2021;14:3923–3934. doi:10.2147/RMHP.S317511
   PubMed Web of Science ®Google Scholar
• Sayed AA. The progressive public measures of Saudi Arabia to tackle covid-19 and limit its spread. Int J Environ Res Public Health. 2021;18(2):783. doi:10.3390/ijerph18020783
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Memish ZA. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies. Int J Antimicrob Agents. 2020;55(5):105968. doi:10.1016/j.ijantimicag.2020.105968
   PubMed Web of Science ®Google Scholar